Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 study evaluating combination chemotherapy followed by peripheral stem cell transplantation in children with recurrent or refractory …
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease [Phase 3]
A Phase 3 clinical trial evaluated whether adding dexrazoxane to combination chemotherapy reduces cardiac toxicity in children with Hodgkin …
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Low Dose IL-2, Hematopoietic Stem Cell Transplantation, IL2 for GVHD [Phase 2]
Phase 2 trial update evaluating low-dose interleukin-2 in patients undergoing allogeneic hematopoietic stem cell transplantation to address …
-
CLINICAL_TRIALS trial_result · 2014-06-10Clinical Trial Update: Cyclophosphamide as Sole Graft-Versus-Host-Prophylaxis After Allogeneic Stem Cell Transplantation [Phase 2]
Phase 2 study evaluating cyclophosphamide as the sole graft-versus-host disease prophylaxis after allogeneic stem cell transplantation has c…
-
CLINICAL_TRIALS trial_result · 2014-06-02Clinical Trial Update: Efficacy Study of T Cell Depleted Allogeneic Non-myeloablative Stem Cell Transplant [Phase 2]
Phase 2 trial evaluating the efficacy of T cell-depleted allogeneic non-myeloablative stem cell transplantation; the study in Hodgkin lympho…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-26Clinical Trial Update: A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study [Phase 2]
Phase 2 trial update of brentuximab vedotin in patients who previously participated in a brentuximab vedotin study, with results posted.
-
CLINICAL_TRIALS trial_result · 2014-05-19Clinical Trial Update: Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer [Phase 3]
Phase 3 trial evaluating total-body irradiation with or without fludarabine phosphate followed by donor stem cell transplant in hematologic …
-
CLINICAL_TRIALS trial_result · 2014-05-16Clinical Trial Update: Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) Transplants [Phase 1]
Phase 1 trial evaluating total body irradiation with fludarabine followed by combined umbilical cord blood transplants has completed. The tr…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision. [Phase 2]
Phase 2 trial evaluating tailored Hodgkin lymphoma therapy guided by early interim PET to inform treatment decisions, with the study status …
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant [Phase 2]
Phase 2 study evaluating plerixafor to rescue poor mobilizers in autologous stem cell transplantation has completed; results were posted in …
-
CLINICAL_TRIALS trial_result · 2014-05-01Clinical Trial Update: Obatoclax Mesylate, Vincristine Sulfate, Doxorubicin Hydrochloride, and Dexrazoxane Hydrochloride in Treating Young Patients With Relapsed or Refractory Solid Tumors, Lymphoma, or Leukemia [Phase 1]
Phase 1 trial evaluating obatoclax mesylate in combination with vincristine, doxorubicin, and dexrazoxane in pediatric patients with relapse…
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell Lymphoma [Phase 1]
A Phase 1 safety trial evaluating XmAb2513 for Hodgkin lymphoma and Anaplastic Large Cell Lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-11Clinical Trial Update: Bryostatin 1 in Treating Patients With Recurrent or Refractory Hodgkin's Disease [Phase 2]
A Phase 2 trial of Bryostatin-1 for Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-10Clinical Trial Update: Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy [Phase 2]
Phase 2 trial evaluating bortezomib, ifosfamide, and vinorelbine for recurrent or refractory Hodgkin lymphoma in both adult and pediatric pa…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on the safety and tolerability results of PCI-24781 in patients with lymphoma, including Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2014-03-31Clinical Trial Update: T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies [Phase 2]
Phase 2 clinical trial evaluating T-cell depleted allogeneic stem cell transplantation for hematologic malignancies; study is completed with…
-
CLINICAL_TRIALS research · 2014-03-26Clinical Trial Update: Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination [Phase 1, Phase 2]
Open-label Phase 1/2 clinical trial evaluating the safety and tolerability of donor-derived allogeneic B-cell concentrates to support immune…
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Proton Therapy for Hodgkin Lymphoma [NA]
The clinical trial NCT00850200 evaluating proton therapy for Hodgkin Lymphoma has completed and results were posted in 2014.
-
CLINICAL_TRIALS trial_result · 2014-03-17Clinical Trial Update: Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy [Phase 1]
A National Cancer Institute-sponsored Phase 1 trial evaluating sunitinib malate in HIV-positive cancer patients on antiretroviral therapy ha…
-
CLINICAL_TRIALS trial_result · 2014-03-05Clinical Trial Update: Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat [Phase 1]
This is a Phase 1b trial update of AMG 655 in combination with bortezomib or vorinostat for lymphomas, including Hodgkin lymphoma and variou…
-
CLINICAL_TRIALS trial_result · 2014-02-26Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease [Phase 2]
Phase 2 trial evaluating the combination of chemotherapy and radiation therapy in children with previously untreated Hodgkin lymphoma stages…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: Tanespimycin and Bortezomib in Treating Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
Phase 1 trial evaluating the combination of tanespimycin and bortezomib in adults with advanced solid tumors or lymphomas; the study was ter…
-
CLINICAL_TRIALS trial_result · 2014-02-24Clinical Trial Update: TARC After alloSCT in Hodgkin's Lymphoma
This clinical trial update notes the completion of a study evaluating TARC levels after allogeneic stem cell transplantation in patients wit…
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM). [Phase 2]
A Phase 2 trial evaluated the safety and efficacy of adding AMD3100 to a G-CSF mobilization regimen in patients with non-Hodgkin lymphoma, H…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 clinical trial update assessing BeGEV (Bendamustine, Gemcitabine, and Vinorelbine) as induction therapy for relapsed/refractory Hodg…